secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aardvark Therapeutics, Inc. (AARD)
CIK:        0001774857
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009862
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aardvark Therapeutics files updated corporate presentation; no material disclosures.
--------------------------------------------------------------------------------

- Updated corporate presentation dated January 2026 filed with SEC.
- No specific operational, financial, or clinical updates disclosed in the filing.
- Presentation intended for use in investor meetings and posted to company website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526009862/0001193125-26-009862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526009862/ck0001774857-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer